COMMUNIQUÉS West-GlobeNewswire

Dr. Ekta Pandya Named Fellow of Pierre Fauchard Academy, Recognized for Leadership in Dentistry and Children's Oral Health
24/07/2026
Pierre Fauchard Academy Fellow recognized for leadership in dentistry, education, pediatric oral health, and community service Dr. Ekta Pandya, newly named Pierre Fauchard Academy Fellow. NEW PALTZ, N.Y., July 24, 2026 [...]
Ondra Health Names Every Pharmacy That Fills Its GLP-1 Prescriptions, a Disclosure Most Telehealth Platforms Don't Make
24/07/2026
Patients are told to verify their provider before starting GLP-1 treatment. The Los Angeles-based platform publishes its five licensed compounding pharmacies, the prescribing medical group, and full pricing so that [...]
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
24/07/2026
Asimov will help build out protein production and characterization capabilities at Boston University's AI-programmable cloud laboratory, one of 20 nodes in the new NSF national network. Asimov will use these [...]
Dyadic Announces Continued Listing on the Nasdaq Capital Market
24/07/2026
JUPITER, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions [...]
MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease
24/07/2026
Transformative delivery option that may support earlier management of worsening fluid overload with a self-administered option designed for use outside the hospital setting Delivers IV-equivalent diuretic effect through [...]
Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction
24/07/2026
Represents significant milestone in the Company’s ongoing portfolio optimization efforts BRENTWOOD, Tenn., July 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a [...]
Treace to Report Second Quarter 2026 Financial Results on August 7, 2026
24/07/2026
PONTE VEDRA, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
24/07/2026
PRINCETON, N.J., July 24, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the Company will release its second quarter 2026 financial results on Friday, August [...]
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
24/07/2026
Data demonstrate the ability to detect, localize and confirm changes in renal neural activity, supporting continued development of physiology-guided renal denervation THE WOODLANDS, TX, July 24, 2026 (GLOBE NEWSWIRE [...]
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
24/07/2026
– Whole-gland TULSA ablation demonstrates statistically significant superior penile length preservation compared to robotic RP at 1 month – TORONTO, July 24, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF [...]
Communiqué de presse: Sanofi annonce sa décision de ne pas soumettre l’amlitélimab dans la dermatite atopique à des évaluations réglementaires mondiales
24/07/2026
Sanofi annonce sa décision de ne pas soumettre l’amlitélimab dans la dermatite atopique à des évaluations réglementaires mondiales Paris, le 24 juillet 2026. Sanofi a annoncé aujourd’hui l’arrêt du développement [...]
Ipsen provides update on Phase III BOLD trial in biliary atresia
24/07/2026
PARIS, FRANCE, 24 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Phase III BOLD trial evaluating Bylvay versus placebo for patients living with biliary atresia (BA) who have already undergone a [...]
Ipsen fait le point sur l'essai de Phase III BOLD dans l'atrésie des voies biliaires
24/07/2026
PARIS, FRANCE, 24 JUILLET 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) a annoncé aujourd’hui que l'essai de Phase III BOLD, évaluant Bylvay versus placebo chez des patients atteints d'atrésie des voies biliaires (AVB) ayant [...]
Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews
24/07/2026
Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews Paris, July 24, 2026. Sanofi today announced the discontinuation of clinical development of amlitelimab, an OX40- [...]
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
24/07/2026
ALAMEDA, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Scribe Therapeutics Inc. (“Scribe Therapeutics”) (Nasdaq: SCTX), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed [...]
Codexis Announces Pricing of Public Offering of Common Stock
24/07/2026
REDWOOD CITY, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex oligonucleotide therapeutics, today [...]
SodaSlim Capsule Label Guide: What the Supplement Facts Panel, Serving Directions, and Safety Statements Disclose for 2026
24/07/2026
SodaSlim's Caffeine Anhydrous, Green Tea Extract, Garcinia, Raspberry Ketone, and Green Coffee Bean Extract Amounts and Sourcing Ogden, UT, July 23, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by [...]
Core Axis Introduces Science-Driven Supplement Protocol Developed Specifically for Hashimoto's Thyroiditis
24/07/2026
Cheyenne, Wyoming, July 23, 2026 (GLOBE NEWSWIRE) -- Core Axis , a health brand founded by MC Bio-Logic LLC, announces the upcoming launch of its daily supplement protocol developed with Hashimoto's thyroiditis in mind [...]
Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report
23/07/2026
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended June 30, 2026 [...]

Pages